The Mater Misericordiae Hospital is a 105-bed hospital in North Mackay, Mackay, Mackay Region, Queensland, Australia. It is operated in the Mercy tradition.

During the past decade, Mater Adult Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mater Adult Hospital" are "Breast Cancer" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Mater Adult Hospital" in a lesser frequency.

Most popular intervention types in "Mater Adult Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (1 trials), "GDC-0941" (1 trials), "Paclitaxel" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mater Adult Hospital" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mater Adult Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mater Adult Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mater Adult Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".